Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)-Reference-Cited by-同舟云学术

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)

Published:2024-07 Issue:1 Volume:86 Page:52-60
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Armstrong Wesley R.^ORCID,Kishan Amar U.,Booker Kiara M.,Grogan Tristan R.,Elashoff David,Lam Ethan C.,Clark Kevyn J.,Steinberg Michael L.,Fendler Wolfgang P.,Hope Thomas A.,Nickols Nicholas G.,Czernin Johannes,Calais Jeremie^ORCID

Publisher

Elsevier BV

Reference31 articles.

1. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy;Stephenson;JAMA,2004

2. Clinical outcomes for patients with Gleason score 9–10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis;Kishan;Eur Urol,2017

3. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial;Pollack;Lancet,2022

4. Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09/10 randomized phase 3 trial;Ghadjar;Eur Urol,2021

5. Radiation with or without antiandrogen therapy in recurrent prostate cancer;Shipley;N Engl J Med,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: Wesley R. Armstrong, Amar U. Kishan, Kiara M. Booker, et al. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774). Eur Urol 2024;86:52–60;European Urology;2024-08

2. Lymph node oligometastases from prostate cancer: extensive or localized treatments - do we have a basis to decide?;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-12

3. Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial;Practical Radiation Oncology;2024-07

4. Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management;The Lancet;2024-06